Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1995-05-15
1997-02-11
Henley, III, Raymond
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514171, 514561, 514565, 514665, A61K 31445, A61K 3156, A61K 31195, A61K 3113
Patent
active
056021500
ABSTRACT:
The present invention relates to a method of treatment and a composition used to prevent the development of the adverse manifestation of tardive dyskinesia in individuals suffering from mental illness such as schizophrenia and undergoing treatment with neuroleptic or antipsychotic agents. The experimentally-based rationale for the present invention indicates that conventional neuroleptic drugs induce tardive dyskinesia because they evoke a glutamate afflux whose excitotoxic action is unopposed by other properties of these drugs, including dopamine receptor blockade. The present invention provides effective drug therapies for schizophrenia comprising conventional neuroleptics or antipsychotic drugs given in combination with taurine, a taurine precursor such as hypotaurine, taurine derivatives, or compounds similar in action to taurine, to render benign tardive dyskinesia as an adverse effect. The combined administration of any of the conventional neuroleptics with taurine and the like offers the benefits of a safe and effective treatment that is generally affordable and vastly improves upon the limited, existing drug treatments which frequently exert crippling and long-lasting side effects unless drug is withdrawn.
REFERENCES:
patent: 4271189 (1981-06-01), Durlach
The Merck Manual, 14th ed., published by Merck & Co., Inc., pp. 2334-2337. 1982.
Henley III Raymond
Research Foundation for Mental Hygiene, Inc.
LandOfFree
Treatment of central nervous system disorders associated with ps does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of central nervous system disorders associated with ps, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of central nervous system disorders associated with ps will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-342451